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The  brain  continues  to  develop  during  adolescence,  and  exposure  to  exogenous  substances
such as  nicotine  can exert  long-lasting  adaptations  during  this  vulnerable  period.  In  order
to fully  understand  how  nicotine  affects  the  adolescent  brain  it is important  to  understandeywords:
dolescence
refrontal cortex
icotine
normal  adolescent  brain  development.  This  review  summarizes  human  and  animal  data
on  brain  development,  with  emphasis  on  the  prefrontal  cortex,  for its important  function
in executive  control  over  behavior.  Moreover,  we  discuss  how  nicotine  exposure  during
adolescence  can disrupt  brain  development  bearing  long-term  consequences  on  executive
cognitive  function  in adulthood.evelopment © 2011 Elsevier Ltd. All rights reserved.
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Box 1: Adolescence in rodents.
Adolescence is a developmental period that is con-
served between mammalian species, and serves an
important purpose, since this is the period between
childhood and adulthood when animals leave their
protected nest-environment. Similar to human ado-
lescents, their rodent counterparts show incremented
social behavior compared to juveniles and adults, such
as increased peer-directed interactions, which can be
observed as an elevation of social play behavior. Also,
adolescents show elevated levels of impulsivity (for
review, Spear, 2000). Another characteristic of adoles-
cence that is shared between mammalian species is
the increased sensitivity to the rewarding effects of
drugs of abuse, such as nicotine, and a decreased sen-
sitivity to withdrawal (for review, O’Dell, 2009) (seeReferences .  .  .  . . .  .  . . . . .  . .  .  .  .  .  .  .  .  .  . .  . . . . . . .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  
1. Rationale
Adolescence is the developmental period during which
individuals undergo the mental transition from childhood
to adulthood, and an individual’s adult personality is being
formed. During adolescence, most individuals will for the
ﬁrst time engage in close relationships outside the borders
of their family. Peers become increasingly important, thus
making adolescents more independent from their family
members. Besides these increments in peer-directed social
interaction, both human and other mammalian adolescents
show increased rates of impulsivity and risk-taking (Spear,
2000). This seemingly maladaptive impulsive behavior
might be very useful since it may  increase the chances to
ﬁnd a partner and to reproduce, and is probably due to
ongoing development of the brain.
Brain development does not stop at birth, but continues
in childhood and throughout adolescence. Initially synaptic
connections of neuronal cells are overproduced and recep-
tor levels increased, and subsequently activity-dependent
processes are engaged to ﬁne-tune adult levels of con-
nectivity and signaling toward the end of adolescence.
Also, myelination of axons increases during adolescence,
thereby increasing processing speed. In particular long-
range connections between different brain regions have
not yet completely matured, and the crosstalk between
different brain areas still has to reach a ﬁnal balance. As
a consequence, developing adolescent brains are function-
ally different from adult brains (Ernst et al., 2005; Eshel
et al., 2007). Therefore, it is conceivable that abnormal brain
development during adolescence that arises from the inter-
play of genetic and environmental factors such as drugs of
abuse, might result in a partial maintenance of the adoles-
cent state, thereby leaving adult individuals with features
of adolescence.
High rates of impulsivity and risk-taking behaviors that
are evident in adolescents are thought to result in the
experimental use of alcohol, tobacco (nicotine) and illicit
drugs (Chassin et al., 1996; Spear, 2000). Substance use
disorders identiﬁed in adults most commonly have their
onset in adolescence or in young adulthood (Chambers
et al., 2003). Early onset substance use is a risk factor to
develop substance use disorder or addiction, and leads
to greater addiction severity and morbidity (Anthony and
Petronis, 1995; Kandel et al., 1992; Taioli and Wynder,
1991). In fact, most adult smokers have started their
habit long before the age of 19 and several retrospective
and prospective studies have suggested that early onset
of smoking may  predict cigarette smoking and nicotine
dependence in adulthood (Brown et al., 1996; Chassin
et al., 1996; Dappen et al., 1996). Speciﬁcally, even smok-
ing a few cigarettes during adolescence was shown to
increase the probability of developing dependence for nico-
tine, and was shown to lead to a 16-fold increase in
the risk of adult smoking (Chassin et al., 1990; Russell,Fig. 1).
1990). In the Netherlands, 71% of adolescents have tried
a cigarette at least once (Van Andel et al., 2003), and
approximately 40% smoke at least monthly at the age of
19 years. These ﬁgures are comparable to other European
countries (WHO-Europe, 2004), and are even higher com-
pared with the USA, where 25% of adolescents in 12th
grade (age 17–18 years) report cigarette use in the past
30 days (Johnson et al., 2006). Despite all epidemiologi-
cal data, the causative relationship of human adolescent
brain development and drug-induced aberrations thereof,
as well as its consequence for later life are hard to
establish empirically. Both individual genetic differences
and complex gene by environment interactions are con-
founding factors. Importantly, adolescence and adolescent
brain development is well conserved between mammalian
species. Therefore, causal relationships of adolescent drug
exposure and the consequences in adult life can be stud-
ied uniquely in laboratory animals. These also allow for
investigation of molecular and cellular synaptic mecha-
nisms, and drug-induced adaptations over time (Box 1 and
Fig. 1).
In this review, we  focus on the effects of tobacco smok-
ing, and intake of its active substance nicotine. Tobacco
smoking creates the largest number of drug dependent
users worldwide and has tremendous impact on their
health. Here, we assess the effects of nicotine on adoles-
cent brain development and, through this, how it may
cause long-lasting cognitive disturbances. We will discuss
the process of adolescent brain development, the age-
dependent differences in sensitivity toward nicotine, and
the long-lasting effects of nicotine on the prefrontal cor-
tex (PFC) in more detail. The PFC develops strongly during
adolescence, allowing nicotine to impact on its executive
control function. An important feature of this review is that
we are discussing and comparing literature on both human
and animal research.
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McCutcheon and Marinelli, 2009), age comparison from (Andersen, 2003
. Adolescent brain development
In humans, brain development continues throughout
dolescence into early adulthood (Galvan et al., 2006).
tructural and functional neuroimaging approaches have
hown that cortical association areas, such as the PFC,
evelop later than primary sensorimotor areas (Durston
t al., 2006; Gogtay et al., 2004). This developmental
rogram parallels cognitive milestones in human brain
evelopment (for review, Casey et al., 2005). Regions nec-
ssary for primary survival functions, such as motor and
ensory systems, develop well before temporal and pari-
tal association areas, which are involved in basic language
nd attentional skills. In particular, higher-order associa-
ion areas such as the PFC, which are involved in integration
f sensorimotor processes and executive tasks, develop
ast. Because higher-order association areas depend on
lower’ motor and sensory areas for their input, the cross-
alk between these systems changes during development,
onsequently impacting on behavior. It is thought that
he relatively early presence of sensorimotor output pro-
ides a stable input on which the higher cortical areas can
uild (Guillery, 2005). Thus, adolescent brain development
s a dynamic combination of regressive and progres-
ive changes, of which the most important processes are
escribed in more detail below.
For reasons of its late adolescent development, we focus
ere on the PFC. In terms of cortical connectivity, pyrami-
al neurons in the PFC communicate using glutamate as
ig. 2. A summary of the processes occurring during development of the rat 
dolescence in the rat is considered to occur between postnatal day 25 and 50.l stages of human brain development (adapted with permission from
the primary excitatory neurotransmitter. In turn, GABA-
secreting interneurons inhibit the activity of the pyramidal
cells. Tracer studies have shown that many brain areas
have afferent projections to the PFC (mostly to layer II/III),
including thalamic nuclei, the amygdala, areas in the basal
forebrain, and the ventral tegmental area (VTA) (Hoover
and Vertes, 2007; Van Eden et al., 1992). Moreover, local
PFC circuitry is modulated by a variety of neurotransmitters
such as dopamine, serotonin and acetylcholine, which are
produced by small groups of neurons located in the mid-
and hindbrain. The efferent projections of the PFC, originat-
ing mostly from layer V pyramidal neurons, innervate many
brain areas, among which the striatum, amygdala, tha-
lamus, and the VTA comprise important projection areas
(Gabbott et al., 2005).
As shown in Fig. 2, and discussed in more detail
below, the development of the PFC during adolescence is
characterized by continuous innervation (Section 2.1) of
ﬁbers with modulatory neurotransmitters and elimination
(Section 2.2) of overproduced glutamatergic synapses (so-
called synaptic pruning). Also, myelination (Section 2.3)
of long-range connections continues throughout adoles-
cence. In addition, the levels of various neurotransmitter
receptors are adapted (Section 2.4)  to reach adult levels.2.1. Innervation
During adolescence, the input of modulatory neuro-
transmitters and glutamatergic projections from other
prefrontal cortex (adapted with permission from (Casey et al., 2005)).
l CognitiD.S. Counotte et al. / Developmenta
areas into the PFC increases (Cunningham et al., 2002,
2008; Gould et al., 1991; Kalsbeek et al., 1988; Rosenberg
and Lewis, 1995). In the rat and macaque brain it has
been shown that dopamine neurons from the VTA increas-
ingly innervate the PFC throughout adolescence (Kalsbeek
et al., 1988; Rosenberg and Lewis, 1995). In addition,
glutamatergic ﬁbers projecting from the amygdala increas-
ingly innervate GABAergic interneurons in the PFC during
adolescence (Cunningham et al., 2002, 2008). Although
cholinergic innervation of the PFC increases to mature
levels (Gould et al., 1991), this maturation is already
completed before adolescence, as there are no differ-
ences in density of acetylcholinesterase/ChAT positive
ﬁbers between P28 and adulthood in rat (Kiss and Patel,
1992). Despite the sparsely available evidence for this
increased innervation of the PFC during adolescence, alto-
gether these data might suggest that the incremented input
enables the PFC to sustain more efﬁcient integration of
information from different brain regions. In addition to
this notion, there is reason to think that the presynaptic
release machinery matures during adolescence (Counotte
et al., 2010), suggesting that also at synapses within the
PFC signal processing may  proceed in a more efﬁcient
way.
2.2. Synapse elimination
A prominent hallmark of the developing central ner-
vous system is the overproduction of synapses (see above)
that are subsequently eliminated in an activity-dependent
manner. This synaptic pruning may  allow for a more efﬁ-
cient synaptic neuronal network communication (Laughlin
and Sejnowski, 2003). In particular, these processes have
been studied in detail for the neuromuscular junction and
the developing visual system (for review, Buffelli et al.,
2004; Huberman, 2007). Synaptic pruning during adoles-
cence is activity-dependent, which means that connections
that are often used are retained and strengthened, while
those that are used less are eliminated (Lichtman and
Colman, 2000). This type of synapse elimination, speciﬁ-
cally in higher-order association cortices like the PFC, is
believed to underlie the improvement in working mem-
ory that occurs during adolescence (Paus, 2005). Evidence
for synapse elimination in the PFC during adolescence is
sparse. It has been demonstrated in non-human primates
that cortical synapses are overproduced during childhood,
and subsequently eliminated (Elston et al., 2009; Rakic
et al., 1994), but most of this occurs before 18 months of
age, whereas adolescence in the rhesus monkey is broadly
considered to occur between 2 and 5 years of age. In work
performed in macaque monkeys, Bourgeois and colleagues
(Bourgeois et al., 1994) described that about half of the
synapses per cortical neuron that were present at the time
of the peak of synaptogenesis are eliminated, but they also
described that during early adolescence (from 2 months
to 3 years of age) there is a plateau phase during which
synapse density remains unchanged. A complicating fac-
tor in the interpretation of synapse elimination is that
differences may  reside in different brain regions (Elston
et al., 2009). In the rhesus monkey PFC, electrophysio-
logical data show that before synapse elimination occurs,ve Neuroscience 1 (2011) 430– 443 433
most synapses are already mature (Gonzalez-Burgos et al.,
2008), suggesting that in the PFC synapse elimination is not
directed at immature synapses.
In the human cortex, synapse elimination during ado-
lescence has also been described (Huttenlocher, 1979,
1990). Nonetheless, the limited number of adolescent
brains used in these studies prevents ﬁrm conclusions
about synapse elimination or a decrease in synapse pro-
duction. Moreover, in these studies, spines are counted
and regarded as synapses, whereas this is in fact only
the postsynaptic element. The use of such measures can-
not provide a full answer, due to potential absence of a
presynaptic element and thus a full functional synapse.
Studies of synapse elimination in the developing visual
cortex (Huberman, 2007) or the neuromuscular junction
(Buffelli et al., 2004) have taken the presynaptic terminal
into account, and show that development of circuits in the
nervous system involves the elimination of synapses.
Neuroimaging studies have been used as an alterna-
tive and non-invasive method to study brain development
during human adolescence. Structural magnetic resonance
imaging (MRI) studies have shown that grey matter density
increases during childhood, with subsequent grey mat-
ter density loss during adolescence (Giedd et al., 1999;
Jernigan et al., 1991; Sowell et al., 2001). The latter has
often been interpreted as synapse elimination. However,
MRI  resolution is not adequate to study changes at the sub-
cellular level, and only reﬂects use of neuronal circuitry at a
higher level of function. Loss of grey matter may  also reﬂect
other developmental changes, such as a change in the num-
ber of glial cells or blood vessels, or changes in neuronal
activity other than elimination of synapses, e.g. neuronal
cell loss. In rats, it has been shown that in the PFC, neuronal
numbers decrease speciﬁcally in ventral regions (Markham
et al., 2007). Although this process has not been investi-
gated for human cortical development, it may  explain the
decrease observed in grey matter during adolescence.
In conclusion, as yet there is only sparse data available in
favor of synapse elimination in the (m)PFC during adoles-
cence, and the underlying mechanisms remain to be solved.
2.3. Myelination
Postmortem research of human brain development has
shown that myelination begins toward the end of the
second trimester of gestation, and extends until approx-
imately 30 years of age (Yakovlev, 1967). Similar to
developmental changes in grey matter density, primary
motor and sensory areas show myelination at an early
stage (during childhood), whereas higher-order associa-
tion areas like the PFC are myelinated during adolescence
(Giedd, 2004). As myelin increases the speed of signal trans-
duction along axons, increased myelination is thought to
improve communication between distant brain areas. The
increased myelination of axons that occurs during ado-
lescence was  shown using immunohistochemical staining
techniques (Benes, 1989), T1-weighted MRI  (Benes, 1989;
Paus et al., 1999), or using diffusion tensor imaging (DTI)
(Snook et al., 2005) (for review see, Klingberg, 2006).
In the rat hippocampus, myelin staining revealed that
myelination stops before adolescence (P25), after which
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t remains stable (Meier et al., 2004). However, Bockhorst
nd coworkers showed (using DTI) that myelination is still
ngoing during adolescence, with an increase in myelin in
he body of the corpus callosum (but not the splenium and
enu) from P21 up to P56 (Bockhorst et al., 2008). They
lso showed that some brain regions, including the exter-
al capsule, internal capsule and anterior commisure are
lready fully myelinated at P28 (Bockhorst et al., 2008).
hese observations argue for distinct temporal differences
n myelination in speciﬁc brain regions during adolescence.
.4. Receptor level adaptations
During adolescent brain development, the expression of
arious types of receptors changes, in order to reach adult
evels at the end of adolescence. In this section, we will
ocus on glutamate receptors, as most PFC synapses are
lutamatergic, and on dopamine and acetylcholine recep-
ors given their importance in modulating PFC circuitry and
ediating (nicotine) reward signals.
.4.1. Glutamate receptors
Glutamate receptors can be classiﬁed as ionotropic
ion channels) or metabotropic (G-protein coupled recep-
ors). Ionotropic receptors, and speciﬁcally the GluN2A
nd GluN2B subunits of the N-methyl-D-aspartic acid
NMDA) receptor, are known to be involved in synaptic
lasticity, and their expression is dependent on synap-
ic activity (Hoffmann et al., 2000). Although it has not
een studied in the PFC speciﬁcally, newly formed synapses
xpress more GluN2B-containing NMDA receptors than
luN2A-containing ones (for review, Carpenter-Hyland
nd Chandler, 2007). Brain expression of both GluN2A
nd GluN2B follows an inverted U-shape (Jin et al., 1997)
Barria and Malinow, 2002) during development. The level
f GluN2B expression is low before birth, and subsequently
ncreases and peaks around the start of adolescence (P30
n the rat; see Fig. 1 in Box 1). Subsequently, it decreases
o reach the adult level of expression. GluN2A recep-
ors are not expressed until shortly after birth, and also
ncrease during development to peak around P30 (Jin
t al., 1997). This differential expression pattern is prob-
bly important for experience-dependent plasticity, and
s also observed in brain regions important for learn-
ng and memory (Carpenter-Hyland and Chandler, 2007).
lthough GluN2A receptors have higher peak currents
nd a greater open channel probability (Chen et al.,
999), GluN2B-containing receptors have higher afﬁn-
ty for agonists and confer greater calcium inﬂux than
luN2A-containing receptors due to their slower inacti-
ation kinetics (Krupp et al., 1996). These characteristics
ave implicated GluN2B as being particularly important
n experience-based plasticity. From our own proteomics
tudy on rat medial PFC (mPFC) synapses, it appears that
here is no change in the expression of GluN2A and GluN2B
etween early adolescence and adulthood (Counotte et al.,
010). This might indicate that the differential develop-
ental expression of GluN2A and GluN2B occurs in only a
ew synapses and is therefore not observed in homogenate
f mPFC synaptic membranes. Neither did we observe
he developmental regulation of -amino-3-hydroxy-5-ve Neuroscience 1 (2011) 430– 443
methyl-4-isoxazolepropionic acid (AMPA) receptors, the
other subclass of ionotropic glutamate receptors (Counotte
et al., 2010). Since developmental changes of both AMPA
and NMDA receptors in the mPFC during adolescence have
been shown to be cell-speciﬁc (Wang and Gao, 2009), we
may  not have observed these cell-speciﬁc alterations in an
mPFC cell homogenate.
Metabotropic glutamate receptors (mGluRs 1–5) are
coupled to G-proteins and modulate glutamatergic trans-
mission through various signal-transduction pathways.
mGluRs are differentially expressed during development,
with gradients of expression. For example, mGluR1 is
expressed earlier in superﬁcial layers of the cortex than in
the deeper layers, reaching an adult pattern of expression
around P35 (Defagot et al., 2002). For mGluR2/3 a similar
gradient was  observed in the striatum, where a gradient in
intensity from dorsal to ventral and from medial to lateral
was  observed (Jokel et al., 2001). This differential pat-
tern becomes homogenous already in the second and third
postnatal weeks. In addition, the developmental pattern
of mGluR4 is again different, with peak expression at P4,
after which the labeling of neuronal cell bodies decreased
throughout development to adult levels (Defagot et al.,
2002).
2.4.2. Dopamine receptors
Dopamine receptors (DRD) also belong to the class of
G-protein coupled receptors, and they fall into two  cate-
gories. DRD1 and DRD5 belong to the D1-like family, and
are coupled to activating G-proteins, causing an increase of
2nd messengers, whereas DRD2, DRD3 and DRD4 belong
to the D2-like family of receptors, which are coupled to an
inhibitory G-protein, and hence their activation leads to a
decrease of cyclic AMP  (Seamans and Yang, 2004).
For the development of both families of dopamine
receptors, an inverted U-shaped developmental expression
pattern has been demonstrated. For instance, in adolescent
rats, the level of dopamine DRD1 receptors on PFC out-
put neurons projecting to the nucleus accumbens is higher
than in younger or adult rats (Brenhouse et al., 2008). This
seems to be a cell speciﬁc regulation, since the level of
DRD1 receptors on GABAergic interneurons in the PFC does
not change during adolescence. Also, DRD2 receptors were
found to attenuate local excitatory synaptic transmission in
the PFC in adulthood, but not yet in adolescence (Tseng and
O’Donnell, 2007), indicating subtle developmental differ-
ences in dopamine modulation of PFC circuitry that occur
during adolescence.
2.4.3. Nicotinic acetylcholine receptors
Given the focus of this review on differential effects of
nicotine on adolescent versus adult brain development and
behavior, it is of interest to investigate the developmental
regulation of nicotinic acetylcholine receptors (nAChRs).
Nicotinic receptors are pentameric ligand-gated ion chan-
nels that can be either homomeric (of which the 7-type
is the most common) or heteromeric (of which the high-
afﬁnity 42-type is most common) (Gotti et al., 2007). In
rats, higher expression of 42 and 7 nAChRs in adoles-
cents versus adults has been reported in the majority of
brain regions, including the nucleus accumbens and the
l CognitiD.S. Counotte et al. / Developmenta
lateral septum (Doura et al., 2008; Trauth et al., 1999).
Speciﬁcally, in adolescence binding to 42 receptors in
slices is higher in most brain regions, such as the nucleus
accumbens, frontal cortex and the visual cortex, whereas
binding to 7 receptors is higher most notably in the
substantia nigra. Binding to 6-containing receptors is
similar between adolescent and adult rats (Doura et al.,
2008). In mice, the developmental pattern of 42 nAChRs
was studied at multiple time points, and follows a simi-
lar inverted U-shape pattern observed with other types of
receptors (e.g. dopamine receptors), with peak expression
levels at P21 (age of weaning, earlier than adolescence),
and following this period declining to adult levels (Yu
et al., 2007). In humans, similar expression patterns were
observed in a PET imaging study; binding to 2-containing
nAChRs declines with age from 18 years on (Mitsis et al.,
2007). Regarding the downregulation of different types of
receptors between adolescence and adulthood, it is dif-
ﬁcult to determine whether these receptors are already
expressed to a lesser extent or, alternatively, whether
the postsynaptic cells or presynaptic terminals expressing
these receptors are eliminated altogether.
In summary, many developmental processes are ongo-
ing during (and maybe even following) adolescence. Both
the number of synapses and the levels of various receptor
types follow a similar pattern with high expression lev-
els during childhood, leading to peak levels in adolescence,
followed by a decline to adult levels. In addition, the myeli-
nation and innervation of several brain regions increases
during adolescence. For some of these processes it has been
shown that they occur early during development in ‘evo-
lutionary older’ regions, and occur late in development of
association areas, such as the prefrontal cortex. Altogether,
different developmental stages make the adolescent brain
different from the mature adult brain, which in turn might
lead to differences in behavior and a differential sensitivity
to drugs of abuse, such as nicotine.
3. Differential sensitivity to nicotine during
adolescence
Next, we will discuss whether adolescents, perhaps
because their brain is still developing and/or because they
show a different nicotine-induced regulation of nicotinic
receptors, are differentially sensitive to nicotine’s effects.
These differences can be attributed to the rewarding prop-
erties of the drug, but also in the severity of withdrawal
symptoms that adolescents experience when they dis-
continue nicotine (e.g. tobacco) use. Obviously, there are
numerous external factors that are unique to human ado-
lescents, such as sensitivity to peer pressure that will make
them more prone to initiate smoking than adults.
3.1. Rewarding properties
The addictive properties of drugs of abuse such as nico-
tine can be measured in laboratory animals using various
behavioral paradigms (e.g., conditioned place preference
(CPP) and self-administration of drugs), either making use
of forced or voluntary intake of drugs (O’Dell and Khroyan,
2009). Many studies have demonstrated that adolescent
animals are more sensitive to display CPP for nicotine thanve Neuroscience 1 (2011) 430– 443 435
adult animals, and that nicotine produces place prefer-
ence at lower doses in adolescents compared to adults
(Belluzzi et al., 2004; Brielmaier et al., 2007; Shram et al.,
2006; Torres et al., 2008; Vastola et al., 2002). Although this
difference in reward sensitivity may  be due to an imma-
turely developed and more sensitive reward system, the
study by Torres et al. showed that the ﬁndings with nico-
tine could not be generalized to different drugs of abuse,
such as the psychostimulant amphetamine (Torres et al.,
2008). However, others showed that differences in CPP
for psychostimulants between adolescents and adults are
dependent on the dose that is used, since adolescents show
CPP at lower doses than adults (Brenhouse and Andersen,
2008; Zakharova et al., 2009).
A better way  of evaluating whether drugs are more
rewarding is to have animals self-administer nicotine.
Despite some experimental difﬁculties, adolescent rats
learn to self-administer nicotine intravenously in instru-
mental self-administration paradigms (Chen et al., 2007;
Levin et al., 2003). Interestingly, there are some reports
describing that adolescent animals self-administer more
nicotine compared to adults (Chen et al., 2007; Levin
et al., 2003, 2007). However, the contrary has also been
reported. In particular, with lower doses of nicotine or
higher response requirements to obtain an infusion of nico-
tine, adolescent rats were less willing to self-administer
nicotine compared to adults (Shram et al., 2008a,b). In
both behavioral paradigms it seems that the dose of nico-
tine used determines whether adolescents are shown to
be more sensitive to nicotine, suggesting that it is not a
straightforward relationship, and research into this aspect
is required.
In humans it is difﬁcult to recruit adolescents and adults
who have smoked at a given age for a similar time span and
have experienced a comparable amount of nicotine intake,
since most adult smokers have started their habit already
during adolescence. In addition, adults who only started
smoking after they had reached adulthood may  form a dif-
ferent population (i.e. genetically) than adolescents who
have started smoking early, and may  as a result differ in
terms of vulnerability to start smoking, as well as in relapse
to smoking. Possibly for these reasons, studies compar-
ing adolescent and adult smokers are sparse. In contrast,
a vast amount of literature describes the progression of
adolescent smokers from recreational to compulsive use
and nicotine dependence. These studies conclude that com-
pared with adult smokers, adolescents tend to smoke with
less regularity, and they smoke less cigarettes per day (for
review, Colby et al., 2000). Regardless of how dependence is
measured (usually using a questionnaire), adolescents are
typically classiﬁed as dependent at only half of the intake-
rate of adults (Prokhorov et al., 1996). Also, compared with
adults, adolescents at the same level of self-reported intake,
were more likely to be diagnosed as dependent (Kandel and
Chen, 2000). Moreover, adolescents consider themselves
to be addicted at much lower levels of use and adoles-
cents who  start smoking regularly continue to smoke well
into adulthood. Taken together, even though adolescents
smoke fewer cigarettes than adults, they are considered to
become more easily dependent. This is in line with most
of the animal literature stating that adolescents are sensi-
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ive to the rewarding effects of nicotine at lower doses than
dults. When adolescents start to smoke, the sensation of
heir ﬁrst smoking experience is associated to later depen-
ence, in a manner that those who experience dizziness,
ausea and relaxation in response to their ﬁrst cigarette are
ore likely to develop symptoms of nicotine dependence
Audrain-McGovern et al., 2007; DiFranza et al., 2004).
.2. Withdrawal symptoms
Another potential difference between adolescent and
dult rats regarding their sensitivity to nicotine is dimin-
shed withdrawal from repeated nicotine administration.
hen adolescent and adult rats were treated with nico-
ine, and subsequently given the nicotinic acetylcholine
eceptor antagonist mecamylamine to precipitate with-
rawal, adults showed more somatic signs of withdrawal
O’Dell et al., 2004), and a higher conditioned place aver-
ion for mecamylamine (O’Dell et al., 2006, 2007; Shram
t al., 2008c).  Spontaneous withdrawal from nicotine, how-
ver, did not produce differences in physical withdrawal
igns between adolescent and adult animals (Shram et al.,
008c). In conclusion, although adolescent animals might
e less sensitive to the negative withdrawal effects – to our
nowledge – it is unknown how this would translate into
icotine dependence.
In support of the view that adolescents are less sen-
itive to nicotine withdrawal effects (O’Dell et al., 2004,
006, 2007; Shram et al., 2008c), human adolescents who
uit smoking with the help of a nicotine patch report
ewer withdrawal symptoms than adults. In the ﬁrst few
ays withdrawal experiences were mild in both adults
nd adolescents, but after this initial period adolescents’
ithdrawal reports declined whereas adult levels of with-
rawal signs remained relatively steady over a 6-week
eriod (Smith et al., 1996). A confounding factor in this
atter study is that many adolescents reported smok-
ng in the period during which they were supposed to
ave quit smoking, whereas adults were in a controlled
moke-free setting (Colby et al., 2000). In another study,
o differences in severity of nicotine withdrawal symp-
oms were found between adolescent and adult smokers,
lthough there were clear age and age by gender effects
n the type of withdrawal symptoms perceived (Pergadia
t al., 2010). Although self-report measures of smoking and
ithdrawal symptoms make it difﬁcult to draw deﬁnitive
onclusions, current human data are in line with pre-
linical data showing that adolescents are less sensitive
o speciﬁc withdrawal symptoms. However, in light of
he above-discussed increased likelihood to initiate and
aintain smoking in adolescents, it is unlikely that dimin-
shed or altered withdrawal symptoms play a crucial factor
n becoming nicotine-dependent. The increased liability
o become dependent on nicotine is merely due to the
nhanced rewarding effects of nicotine during adolescence
for review, O’Dell, 2009).
.3. Is differential sensitivity due to regulation of
icotinic receptors?
One of the explanations for a different sensitivity in
icotine in adolescents may  be that nicotinic receptorsve Neuroscience 1 (2011) 430– 443
are differentially regulated by nicotine during develop-
ment. Nicotine acts on nicotinic acetylcholine receptors.
Repeated or prolonged nicotine exposure increases the
number of high-afﬁnity (mainly 42) nicotine bind-
ing sites, in heterologous systems (Kuryatov et al., 2008;
Tumkosit et al., 2006), nicotine-treated animals (Marks
et al., 1983; Schwartz and Kellar, 1983; Yates et al., 1995),
and in postmortem brains of smokers (Benwell et al., 1988;
Breese et al., 1997; Perry et al., 1999) (for review, Govind
et al., 2009). The nicotine-induced up-regulation of nAChRs
in the brain is both subtype and region speciﬁc (Lai et al.,
2005; Moretti et al., 2010; Mugnaini et al., 2006; Nashmi
et al., 2007; Perry et al., 2007; Xiao et al., 2009). Inter-
estingly, adolescent nicotine exposure has been shown to
lead to larger and longer-lasting changes in nAChR binding
(Abreu-Villaca et al., 2003; Doura et al., 2008) and function
(Kota et al., 2009) in brain regions such as cortex and stria-
tum, which may  (in part) underlie the enhanced sensitivity
of adolescents to nicotine.
3.4. Other factors that inﬂuence adolescent smoking in
humans
In addition to the physical effects and enhanced sen-
sitivity to the rewarding effects of nicotine, it must be
noted that smoking is more than just inhaling nicotine.
Not only because cigarettes contain a wealth of sub-
stances other than nicotine, for example acetaldehyde,
which in adolescent but not adult rats facilitates the rate
of self-administration of nicotine (Belluzzi et al., 2005),
but also because smoking in vulnerable individuals quickly
becomes a complex addictive habit. Smoking in human
adolescents is determined by various factors, such as peer
pressure and individual differences in impulsivity and
risk-taking. Especially, when their best friend smokes, ado-
lescents between 12 and 15 years are at a higher risk
to initiate smoking (a relative risk of 10 for boys and 15
for girls between the age of 12–15 years) (Vink et al.,
2003). This relative risk is much lower at the age of 21–40
years, as it decreases by half with age, demonstrating that
adolescents are speciﬁcally vulnerable for peer-pressure.
This environmental risk is even further increased in those
individuals who  have a higher degree of impulsivity and
risk-taking behavior, such as individuals with ADHD (for
review, McClernon and Kollins, 2008). From a biological
point of view one might argue that the adolescent brain,
and in particular association areas like the PFC, has not
yet fully developed, causing adolescents to show increased
impulsive and risk-taking behavior, and do not oversee
the long-term consequences of their behavior. As a result,
many adolescents believe there are no health risks in the
ﬁrst few years of nicotine exposure, and they believe that
they will be able to stop before the damage is done (Arnett,
2000). In particular, because nicotine-related cues act on
the same cortical (o.a. PFC) brain areas in adolescent mod-
erate smokers as in adults (Lee et al., 2005; Rubinstein et al.,
2011), adolescents apparently exhibit heightened reactiv-
ity to smoking cues that in turn could impact on initiation
and maintenance of smoking.
In conclusion, both human and rat adolescents seem
to be more sensitive to some of the effects of nicotine
l CognitiD.S. Counotte et al. / Developmenta
compared to their adult counterparts. Adolescents become
dependent after having smoked fewer cigarettes, and are
much less aware of the risks of smoking, collectively caus-
ing many adolescents to start and continue smoking far
into adulthood. In terms of human health, this leads to the
important question what the long-term effects of adoles-
cent exposure to nicotine are.
4. Long-term effects of nicotine during adolescence
Addictive drugs such as nicotine and alcohol are legal
in our society, and therefore, these substances are often
the ﬁrst type of drugs of abuse people experience in their
lives. Regarding nicotine, 71% of Dutch adolescents have
tried a cigarette at least once, often leading to long-term
use. These numbers have led to efforts to better understand
what the long-term effects of early nicotine use are, both
in prospective and longitudinal human studies, as well as
in preclinical animal studies.
4.1. Adolescent nicotine and its effects on cognitive
functioning
The brain’s cholinergic signaling system is important
for a variety of cognitive functions, such as attention,
inhibitory control and decision-making mechanisms, the
latter two subserving impulse behavior (Everitt and
Robbins, 1997; Pattij and Vanderschuren, 2008). Nicotine,
similar to the endogenous ligand acetylcholine, acts by
modulating synaptic signaling through increased neuro-
transmitter release in the brain (for review, Mansvelder
et al., 2009, 2006). Nicotine has often been shown to
enhance speciﬁc aspects of cognitive functioning, such as
selective attention, that is the capacity to maintain a behav-
ioral or cognitive set in the face of distracting or competing
stimuli, in both humans and rodents (Day et al., 2007;
Grottick and Higgins, 2000; Pattij et al., 2007; Rycroft et al.,
2005). Oftentimes, this nicotine-induced enhancement of
cognition is stronger, or even only present, in smokers
compared with non-smokers (or in chronically exposed
rats compared with nicotine-naïve rats). Non-smokers or
drug-naïve rats are sometimes reported not to cognitively
beneﬁt from nicotine at all (van Gaalen et al., 2006), espe-
cially when baseline levels of performance are already high
in the absence of nicotine (Poltavski and Petros, 2006).
4.1.1. Attention
In adolescent smokers disturbances in working memory
and attention have been reported (Jacobsen et al., 2005),
as well as reduced attention-associated prefrontal cortical
blood-oxygen level dependent (BOLD)-responses (Musso
et al., 2007). Thus, these studies suggest some detrimental
effects of nicotine on cognitive functioning during ado-
lescence. Nonetheless, it is important to note that these
studies only focused on the short-term effects of adolescent
smoking on cognition, whereas the levels of smoking were
determined by self-report measures and were not con-
trolled for pre-smoking levels of cognitive performance.
Despite these limitations, they suggest that adolescent
exposure to nicotine may  impair cognitive performance
on the long-term, yet this has never been examined inve Neuroscience 1 (2011) 430– 443 437
humans in more detail. In rats, we recently observed that
adolescent nicotine exposure decreases visual attention
into adulthood, even after a relatively long nicotine-free
period (Counotte et al., 2009). Furthermore, we  discovered
a neurobiological mechanism revealing that these changes
were caused by decreased synaptic expression of mGluR2
in the mPFC that led to disruptions in short-term plastic-
ity (Counotte et al., 2011). Restoring mGluR2 tone by local
infusion of a group II mGluR agonist increased performance
in these animals. These data not only show that adoles-
cent nicotine exposure has long-lasting consequences for
mPFC synapse function and cognition, but also shows the
importance of mPFC mGluR2 in mediating attention.
4.1.2. Impulsive behavior
Smoking appears to be closely related to several forms
of impulsivity in humans. Impulsivity includes categories
of behaviors that result from problems to inhibit behavioral
responses, often referred to as impulsive action, and behav-
iors that reﬂect impulsive decision making, for example,
delay aversion, which is exempliﬁed by increased prefer-
ence for immediate reward over more beneﬁcial delayed
reward (Pattij and Vanderschuren, 2008). In humans, adult
smoking has been associated with both impulsive choice
(Bickel et al., 1999; Mitchell, 1999) as well as deﬁcits
in inhibitory control, when compared with non-smokers
(Mitchell, 1999; Skinner et al., 2004; Spinella, 2002). How-
ever, whether impulsivity in adult smokers results from
nicotine exposure, or alternatively, is a pre-existing vul-
nerability trait predisposing individuals to initiate and
maintain smoking is as yet unclear, since none of these
studies controlled for pre-smoking levels of impulsivity.
Recent preclinical data would support either view; trait
impulsivity in the form of impulsive action may  predict
the vulnerability to initiate and maintain nicotine seek-
ing (Diergaarde et al., 2008), and we  recently found that
adolescent nicotine exposure increases impulsive action
(Counotte et al., 2009). In this respect, nicotine itself
likely exerts a much larger effect on impulsivity, as a
main nicotine effect was  found in a general population
of rats (Counotte et al., 2009, 2011). Hence, differences in
impulsivity might render an individual more vulnerable to
initiate smoking, and depending on the age of intake, this
might create these individuals to become even more impul-
sive and less attentive, which could result in increased
intake of nicotine. However, impulsive choice, that was
found to predict a higher vulnerability to relapse to nicotine
seeking (Diergaarde et al., 2008), was unchanged following
adolescent nicotine exposure (Counotte et al., 2009). Thus,
although this form of impulsivity does not seem to play a
role in the age-dependent effect of nicotine, it suggests that
once individuals with increase levels of impulsive choice
have initiated nicotine use, efforts to quit might become
more difﬁcult (Diergaarde et al., 2008).
To date, human evidence describing the long-term
effects (in absence of nicotine) of adolescent smoking on
impulsivity in adulthood is limited. It has been demon-
strated recently though, that the inability to abstain from
smoking in adolescents is associated with elevated levels
of impulsive action in the continuous performance task
(Krishnan-Sarin et al., 2007) as well as increased impulsive
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hoice in a real-time delay discounting paradigm (Dallery
nd Raiff, 2007; Krishnan-Sarin et al., 2007), which is com-
arable to the rat delayed reward paradigm. In a different
tudy, young adult smokers show higher rates of delay dis-
ounting than both adolescent smokers and young adult
on-smokers (Reynolds, 2004). The number of cigarettes
moked correlated with delay discounting, but reported
ength of smoking history did not correlate with delay dis-
ounting. This suggests that despite the clear relationship
etween smoking and impulsivity, as yet no conclusion can
e drawn on the long-term adverse effects of adolescent
icotine exposure on delay discounting because the long-
asting effects of smoking on measures of impulsivity in
oth abstinent as well as non-abstinent adolescent smok-
rs and non-smoking adolescents have not been evaluated
Reynolds, 2004).
Collectively, these ﬁndings from human and animal
esearch clearly show that there is a relationship between
icotine exposure and impulsivity, but the exact nature of
his relationship and empirical evidence whether nicotine
xposure causes impulsivity in humans, or pre-existing
mpulsivity increases sensitivity to nicotine, or perhaps
oth, remains to be determined.
.2. Mental health: adolescent nicotine and affective
isorders
There are many reciprocal interactions reported
etween psychiatric disorders and nicotine dependence.
n the one hand, psychiatric patients are more likely
o smoke than the general population; it has been
stimated that 60% of patients with depression and post-
raumatic stress disorder are smokers, and in schizophrenic
atients the prevalence of smoking can be as high as 90%
Fagerstrom and Aubin, 2009). On the other hand, there
re also associations reported between adolescent smok-
ng and the development of mental health problems (for
eview, Mathers et al., 2006). In summary, several studies
ave found that adolescent tobacco use or dependence is
ssociated with the onset of psychiatric disorders, such as
ntisocial personality disorder, major depressive disorder,
nxiety disorder and panic disorder, even after correction
or confounding factors, such as the occurrence of previous
sychiatric disorders (Brook et al., 1998, 2002; Brown et al.,
996; Johnson et al., 2000; McGee et al., 2000; Pedersen
nd von Soest, 2009). Similar to what was observed for
dults, in adolescent patients with schizophrenia rates of
icotine dependence are high (Hakko et al., 2006). How-
ver, there are no studies that have investigated whether
dolescent smoking increases the relative risk to develop
sychosis or schizophrenia. Although (early onset of) psy-
hiatric disorders are predictors of nicotine dependence,
ometimes the start of adolescent nicotine dependence is
receded by the onset of psychiatric disorders (Griesler
t al., 2008).
It is well established that smoking is signiﬁcantly related
o depression (for review, Park and Romer, 2007), how-
ver it is unclear what the direction of this relationship
s. There is evidence that adolescent smoking is a deter-
inant of developing depressive symptoms (Choi et al.,
997a; Goodman and Capitman, 2000), and it has also beenve Neuroscience 1 (2011) 430– 443
shown that adolescents with depressive symptoms are
more likely to start smoking (Escobedo et al., 1998; Kenney
and Holahan, 2008; Prinstein and La Greca, 2009). Also,
individuals with depressive symptoms who start to smoke
during adolescence increase their risk for subsequent
depressive symptoms (Choi et al., 1997b), and depressed
smokers are less likely to quit smoking (Glassman et al.,
1988).
To circumvent the difﬁculty to assess the direction of
the relationship of long-term effects of adolescent nico-
tine use on mental health in humans, one can try to
model this in preclinical animal studies. In particular, ani-
mal  studies allow for controlling various environmental
conditions including housing, food intake and social inter-
actions. Although it may  be difﬁcult to model human
psychiatric disorders in rodents, it is possible to measure
various distinct parameters related to particular endophe-
notypes, such as measures of anxiety, as well as executive
cognitive functions such as attention and impulsive behav-
iors described earlier in this review. In terms of modeling
aspects of affective disorders, indeed, exposing adoles-
cent, but not adult rats to nicotine resulted in an increase
in anxiety-related behavior in adulthood compared with
their control counterparts, observed as less time spent in
the center of an open ﬁeld (Slawecki et al., 2003; Smith
et al., 2006), or on the open arms of an elevated plus maze
(Slawecki et al., 2005). Also, animals exposed to a low dose
of nicotine during adolescence failed to extinguish fear-
related memories in a fear-conditioning task (Smith et al.,
2006). However, in the forced swim task, a behavioral task
that measures depressive-like symptoms such as learned
helplessness, adolescent nicotine exposure decreases these
behavioral symptoms, in conjunction with changes in the
CRF and NPY systems (Slawecki et al., 2005). We  should
note however, that the two studies from Slawecki et al.
did not include an adult group exposed to nicotine, which
makes it harder to draw ﬁrm conclusions.
Taken together, there is a strong relationship between
smoking and mental health disorders, in particular depres-
sion. However, the relationship between these two needs
further study using longitudinal studies in humans, and
preclinical animal studies to investigate the cellular mech-
anisms by which adolescent nicotine exposure causes
mental health problems.
4.3. Mental health: adolescent nicotine and drug
dependence
Adolescent use of tobacco has been described to pre-
cede initiation and subsequent use of other (illicit) drugs
of abuse, a theory generally known as the gateway hypoth-
esis (Kandel, 1975). When looking at the age of ﬁrst use,
both alcohol and nicotine use precede use of illicit drugs of
abuse, such as cocaine and heroin (Arria et al., 2008), but
it is unclear as to whether these observations are causally
related. A recent review elegantly summarized all prospec-
tive and longitudinal studies that investigated the effects
of adolescent smoking on subsequent use of other drugs
of abuse (Mathers et al., 2006). In particular, adolescent
tobacco smoking is associated with subsequent alcohol
abuse and dependence, even after controlling for several
l CognitiD.S. Counotte et al. / Developmenta
potential confounding factors, such as psychiatric disor-
ders, demographic factors and parental education (Brook
et al., 2002; Jackson et al., 2002; Lewinsohn et al., 1999).
Although several studies reported that tobacco use pre-
dicts or is related to later use of cannabis (Ellickson et al.,
2001; Kandel et al., 1986; McGee et al., 2000), confound-
ing factors, such as demographic factors and psychiatric
disorders, have not been adjusted for. Thus, although
the gateway hypothesis seems to apply to most studies
examining smoking as prediction for illicit drug use, cor-
rections for confounding factors have oftentimes not been
performed (Ellickson et al., 2001; Johnson et al., 1995;
Kandel et al., 1986; Lewinsohn et al., 1999). In this regard,
only a single study reports a clear association between
adolescent smoking and subsequent use of illicit drugs
after controlling for confounding factors (Brown et al.,
1996). Nonetheless, recent work examining the relation-
ship between adolescent tobacco use and illicit drug use
contrasts this observation and reports that there is no
signiﬁcant association after controlling for demographic
factors, psychiatric disorders and substance use disorders
(Brook et al., 2002).
The difﬁculty to control gene by environment interac-
tions in the human population hampers a straightforward
interpretation of adolescent nicotine exposure on subse-
quent behavioral changes. Animal models can therefore
greatly contribute to our understanding of the adolescent
brain and can thus be used to explore putative causal rela-
tionships between early drug exposure during adolescence
and vulnerability to drugs later in life. Adolescent, but not
adult nicotine exposure has been shown to increase the
locomotor response to amphetamine as long as 30 days
after nicotine was given (Collins et al., 2004). Also, exposing
adolescent rats to nicotine increases intravenous nico-
tine self-administration when rats have reached adulthood
(Adriani et al., 2003), and increases intravenous cocaine
self-administration in late adolescence (McQuown et al.,
2007). In addition, nicotine exposure during early adult-
hood seems to reduce subsequent sensitivity to nicotine.
When rats are only exposed to nicotine following adoles-
cence, this causes a reduction in the rewarding properties
of nicotine, observed as a rightward shift in the conditioned
place preference dose-response curve, suggesting that
lower doses of nicotine were no longer rewarding to them
(Adriani et al., 2006). However, when alcohol-preferring
rats were exposed to nicotine during adolescence, this did
not increase subsequent alcohol intake, compared with
their saline controls (Kemppainen et al., 2009). In conclu-
sion, these data argue for an increased sensitivity to drugs
when exposed during adolescence, and a reduced risk to
develop dependence when exposed following adolescence.
5. Overall conclusion
In conclusion, the brain and speciﬁcally the prefrontal
cortex continue to develop during adolescence, making the
adolescent brain uniquely different from the adult brain.
One of the differences is that adolescents are more sen-
sitive to the rewarding effects of nicotine, which may  be
a reason that many people start to smoke during adoles-
cence. Both prospective and longitudinal human studiesve Neuroscience 1 (2011) 430– 443 439
suggest that adolescent exposure to nicotine has long-term
effects, among which are 1) the risk to develop substance
use disorder and 2) various mental health problems, the
most prevalent ones relating to affective disorders such
as anxiety and depression. In addition, inasmuch our ani-
mal  studies can be extrapolated to humans, adolescent
exposure to nicotine may  lead to decreased attention per-
formance and increased impulsivity on the long-term. The
latter observation in turn might promote the maintenance
of smoking behavior. Based on studies in human subjects,
it is difﬁcult to determine whether adolescent smoking
underlies these problems, or whether smoking and mental
health disorders have a common origin that predisposes
an enhanced risk to the development thereof. In order to
understand the effects of drugs of abuse on motivational
systems, it is important to gain a better understanding of
their development in the adolescent brain. We  believe this
should be done both through longitudinal human studies,
and by using preclinical animal approaches to understand
the precise mechanistic molecular synaptic changes as well
as changes in neuronal circuitry that take place during ado-
lescent development.
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